Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NIKKICART

K-Number: K221652 · 2023-03-03

Decision Date2023-03-03
Product CodeKPO
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

NIKKICART is a medical device manufactured by Renal Care Dialysis Solutions, S.A. DE C.V.. It received FDA 510(k) clearance on 2023-03-03 under approval number K221652. The device is classified under product code KPO. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NIKKICART?

NIKKICART is a medical device that received FDA 510(k) clearance on 2023-03-03. It is manufactured by Renal Care Dialysis Solutions, S.A. DE C.V.. The 510(k) number is K221652.

When was NIKKICART approved by the FDA?

NIKKICART received FDA 510(k) clearance on 2023-03-03, under approval number K221652.

What company makes NIKKICART?

NIKKICART is manufactured by Renal Care Dialysis Solutions, S.A. DE C.V..

What is the FDA product code for NIKKICART?

The FDA product code for NIKKICART is KPO.

Related Devices (Code: KPO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.